Related Pages for PIIND
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Price vs OI
- Time Series
- Volatility Skew
- Premium Decay
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
PIIND
2702.6
Related News - PIIND
PI Industries: Jefferies maintains a Buy on PI Industries with a Target Price of ₹3575, citing Q4 EBITDA and PAT miss due to slower new product growth and sharp contraction in pyroxasulfone along with higher working capital, but expects FY27 recovery from a favorable base and new molecule growth, projecting a 12% adjusted PAT CAGR over FY26–28.
21 May 2026 08:53 AM
PI Industries: Jefferies maintains a Buy on PI Industries with a Target Price of ₹3575, citing Q4 EBITDA and PAT miss due to slower new product growth and sharp contraction in pyroxasulfone along with higher working capital, but expects FY27 recovery from a favorable base and new molecule growth, projecting a 12% adjusted PAT CAGR over FY26–28.
PI Industries: HSBC maintains a Hold on PI Industries with a Target Price of ₹3000, citing another weak Q4FY26 earnings miss due to agri business disappointment and higher overheads pressuring margins, while noting uncertainty around muted core businesses and slower scaling of new businesses leading to earnings cuts.
21 May 2026 08:53 AM
PI Industries: HSBC maintains a Hold on PI Industries with a Target Price of ₹3000, citing another weak Q4FY26 earnings miss due to agri business disappointment and higher overheads pressuring margins, while noting uncertainty around muted core businesses and slower scaling of new businesses leading to earnings cuts.
PI Industries: Citi maintains a Sell on PI Industries with a Target Price of ₹2600, citing weak Q4 EBITDA due to lower CSM exports and agchem revenues, continued losses in Pharma CDMO despite growth, margin pressure, back-ended FY27 recovery expectations, and concerns over pyroxasulfone generic competition and muted agchem outlook.
21 May 2026 08:53 AM
PI Industries: Citi maintains a Sell on PI Industries with a Target Price of ₹2600, citing weak Q4 EBITDA due to lower CSM exports and agchem revenues, continued losses in Pharma CDMO despite growth, margin pressure, back-ended FY27 recovery expectations, and concerns over pyroxasulfone generic competition and muted agchem outlook.
PI Industries: DAM Capital maintains a Sell on PI Industries with a Target Price of ₹2556, citing structural challenges in Agchem CSM, sharp slowdown in legacy exports, weak domestic agchem demand, delayed recovery in Biologicals and exports, margin pressure from higher costs and R&D spend, and EPS cuts for FY27/FY28 due to muted growth outlook.
21 May 2026 08:53 AM
PI Industries: DAM Capital maintains a Sell on PI Industries with a Target Price of ₹2556, citing structural challenges in Agchem CSM, sharp slowdown in legacy exports, weak domestic agchem demand, delayed recovery in Biologicals and exports, margin pressure from higher costs and R&D spend, and EPS cuts for FY27/FY28 due to muted growth outlook.
PI Industries: Morgan Stanley maintains an Overweight on PI Industries with a Target Price of ₹3,883, citing expected return to revenue growth in FY27 driven by improving exports and domestic agchem traction, strong biologicals margins, pharma scale-up potential, US approval for its bionematocide product, and upcoming Pioxaniliprole launch in India.
21 May 2026 08:53 AM
PI Industries: Morgan Stanley maintains an Overweight on PI Industries with a Target Price of ₹3,883, citing expected return to revenue growth in FY27 driven by improving exports and domestic agchem traction, strong biologicals margins, pharma scale-up potential, US approval for its bionematocide product, and upcoming Pioxaniliprole launch in India.
PI Industries: Focuses On Increasing Market Share Through Volume Growth Rather Than Margin Growth, Aiming For Revenue Of Rs 100 Million From Electronic Chemicals In 4-5 Years.
20 May 2026 03:37 PM
PI Industries: Focuses On Increasing Market Share Through Volume Growth Rather Than Margin Growth, Aiming For Revenue Of Rs 100 Million From Electronic Chemicals In 4-5 Years.
PI INDUSTRIES: FINAL DIVIDEND OF 10 RUPEES PER SHARE
19 May 2026 09:19 PM
PI INDUSTRIES: FINAL DIVIDEND OF 10 RUPEES PER SHARE
PI INDUSTRIES: Q4 CONS NET PROFIT 2B RUPEES VS 3.3B (YOY) || Q4 REVENUE 15.6B RUPEES VS 17.9B (YOY)
19 May 2026 09:06 PM
PI INDUSTRIES: Q4 CONS NET PROFIT 2B RUPEES VS 3.3B (YOY) || Q4 REVENUE 15.6B RUPEES VS 17.9B (YOY)
PI INDUSTRIES: Q4 EBITDA 3.3B RUPEES VS 4.6B (YOY) || Q4 EBITDA MARGIN 21.55% VS 25.6% (YOY)
19 May 2026 09:06 PM
PI INDUSTRIES: Q4 EBITDA 3.3B RUPEES VS 4.6B (YOY) || Q4 EBITDA MARGIN 21.55% VS 25.6% (YOY)
